THE SMART TRICK OF PGUFA THAT NO ONE IS DISCUSSING

In its 1997 reauthorization of PDUFA, Congress enacted stricter general performance goals, necessary enhanced transparency while in the drug review course of action, and made an effort to aid better conversation amongst drug makers and individual advocacy groups.When Congress was debating the legislation that applied PDUFA II Rep. Billy Tauzin, who